论文部分内容阅读
目的:探究枯草杆菌二联活菌肠溶胶囊治疗感染性腹泻的临床疗效。方法:收集2015年6月—2016年7月我院收治的感染性腹泻患者60例,随机分为2组各30例,对照组采用静脉注射硫酸依替米星,研究组采用硫酸依替米星联合枯草杆菌二联活菌肠溶胶囊,治疗一周,比较两组患者治疗前后的CRP表达情况、临床症状消失时间及临床疗效。结果:治疗后的CRP表达量均下降,但研究组的CRP表达量优于对照组,另外在临床症状消失时间及疗效方面,研究组也明显更优于对照组,P<0.05。结论:枯草杆菌二联活菌肠溶胶囊治疗感染性腹泻,疗效显著,能及时缓解患者的临床症状,具有显著的临床推广价值。
Objective: To investigate the clinical efficacy of Bacillus subtilis digestive enteric-coated enteric-coated capsules in the treatment of infectious diarrhea. Methods: Sixty patients with infectious diarrhea admitted to our hospital from June 2015 to July 2016 were randomly divided into two groups of 30 patients. The control group was treated with intravenous injection of etimicin sulfate. The study group was given etimicin Star combination of Bacillus subtilis two live bacteria enteric-coated capsules for one week, compared two groups of patients before and after treatment of CRP expression, clinical symptoms disappear time and clinical efficacy. Results: After treatment, the expression of CRP decreased, but the CRP expression in the study group was better than that in the control group. In addition, the study group was significantly better than the control group in the disappearance time and efficacy of clinical symptoms (P <0.05). Conclusion: Bacillus subtilis digestive enteric-coated enteric-coated capsules can treat infectious diarrhea with significant curative effect and can relieve the clinical symptoms of patients in time. It has significant clinical value for clinical application.